UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITY EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2001 Commission file Number 33-22142 REDOX TECHNOLOGY CORPORATION -------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 55-0681106 -------- ---------- State or other jurisdiction of (IRS Employer incorporation or organization Identification Number) 340 North Sam Houston Parkway East, Suite 250, Houston, Texas, 77060 Tel: (281) 445-0020 Securities registered pursuant to Section 12(b) of the act: NONE Securities registered pursuant to Section 12(g) of the Act: NONE COMMON STOCK, PAR VALUE $0.00005 PER SHARE (Title of Class) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 Days. Yes [X] No[ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (Section 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X] The aggregate market value of the voting stock held by non-affiliates of the registrant based on the average bid and asked price of the stock on December 31, 2001 was $4,849,931.00 (APPLICABLE ONLY TO CORPORATE REGISTRANTS) Indicate the number of shares outstanding of each of registrant's classes of common stock, as of the latest practicable date. CLASS NUMBER OF SHARES OUTSTANDING ON: ----- -------------------------------- Common Stock April 20,2002 ----------------- par value $0.00005 59,395,945 1 PART I ITEM 1. BUSINESS OF THE COMPANY Organization The Company initially was incorporated as DCUSA, Inc. under the laws of Delaware on April 28, 1988, organized as a "blind pool," meaning that it had no business plan of its own but was organized to acquire or merge with an active business. Initially the Company was a wholly-owned subsidiary of Family Health Systems, Inc. which held 3,000,000 shares of the Company's Common Stock. Pursuant to a Registration Statement which was declared effective on August 2, 1988, the 3,000,000 shares were distributed as a dividend to approximately 900 Family Health Systems, Inc. stockholders, effectively spinning-off the Company as an independent entity. In early 1993, the Company entered into a relationship with Richard Szymanski who, on April 9, 1993 assigned his recently filed Patent Application for an "Emergency Reserve Battery" to the Company in exchange for 15,000,000 shares of the Company's Common Stock. As a result, Mr. Szymanski owned approximately 82% of the Company's then issued and outstanding Common Stock. On June 1, 1993 the name of the Company was changed to its present name, "ReDOX Technology Corporation." Business History From 1993 until approximately 1996, we were engaged in developing the "Emergency Reserve Battery." The product was, essentially, a single-use battery which would be attached to a car battery as a reserve unit. In the event that the regular battery was fully discharged and unable to start the car, the driver would activate the reserve battery, releasing the electrolyte and charging instantly the reserve battery that would then be used to start the car. The Company built prototypes, attempted to market it to many battery manufacturers, and attempted to secure financing to support manufacture of the product. However, during the same period there were significant changes in battery technology, especially the chemistry including new electro-chemical engineering and processes (such as lithium metal batteries) which offered higher energy densities (storage capacity) than the Company's product. As a result, the Company became engaged in substantial research and development efforts in a search for greater energy density and more flexibility, and the product was never produced and sold. As a result of his research efforts, Mr. Szymanski became aware of the work being done by Professor Licht at Clark University in Worcester, Massachusetts. At that time, the Company's battery was based on an alloy of aluminum, magnesium and zinc as the anode with a carbon-based cathode. Professor Licht was working with aluminum as the anode and sulfur and poly-sulfide as the cathode. Mr. Szymanski began working with Clark University and in September, 1998, after about three years of investigation and negotiations, the Company obtained a Patent License Agreement from Clark University. (see "Property of the Company") From 1998 to December 31, 1999, we were engaged in seeking financing for the production of prototypes, beta testing of the prototypes, completion of product development and establishment of manufacturing. However, the Company has been unable to secure that financing on terms acceptable to it. Using the Clark University technology, and the financing of our President, Mr. Szymanski, prototypes have been developed as of the last quarter of 2000. Although the lab prototypes have been developed, and testing at an independent laboratory has commenced, additional funding is necessary to make production prototypes from the lab prototypes, which will be accomplished only after testing on the lab prototypes is complete and recommended adjustments are made, if any. We have decided to initially develop two of our lab prototypes, with a focus on minimizing battery size, and maximizing cell and ampere-hours. We have been working with a well-known independent research lab, the name of which is contractually being withheld, and this lab will be providing certifications on all 5 patents issued on this technology. Until the results are complete, and certifications are provided, we will be deferring the marketing of this technology and focusing on our software technologies. We believe that our decision to focus on technologies that can more quickly provide the Company with cash flow, such as the computer software technologies discussed below, will benefit the Company and its shareholders. We hope to generate sufficient revenues from our software technologies to fulfill our business objectives, including the completion of our research and testing necessary for our battery technology. It is our belief that that the final development and marketing of our battery technology will be delayed until the second quarter of 2002. During the year 2000, we acquired the world wide exclusive licensing rights for two new computer software technologies: (i) Divine Logic 2000 (also referred to as nCRYPTfx); and (ii) ONSLR e2000; both of which Management feels will generate revenue for the Company. We intend to market sub-licenses to these software technologies directly to computer hardware companies so that the technologies can be installed prior the retail sale of the computer, thereby generating revenue from royalties. Our role, then, will be more a marketing and selling one than a research and developmental one. Richard Szymanski, the founding and majority shareholder, has spent varying amounts of time since 1993 on these research efforts. Mr. Szymanski has taken no salary since inception and has personally funded most operating costs. Until 2001, no significant 2 payments were made to third parties for any research efforts. Thus, the financial statements do not reflect any research and development expenditures until 2001. Proposed Products Software Technologies Divine Logic 2000 is an anti-piracy software program that was developed to prevent the theft of electronic information and unauthorized copying of software. Applications for this product will be in the computer industry, the music CD industry, the DVD movie industry, video games and MP3. This technology differs from existing anti-piracy software programs in that it has the ability to detect when a copy is being made of any file, without limitation to only executable files. Divine Logic 2000 checks graphic files, movie files, text files, etc. This software can be installed directly during the assembly of the computer by the manufacturer, or can be installed indirectly with a CD. Divine Logic 2000 consists of two parts: Divine Logic and Program Immune Virus. Divine Logic detects the pirated software, and Program Immune Virus eliminates or destroys it. The developer, Shaju Chacko, has indicated that the program cannot be detected or debugged using any assembly language. The development of Divine Logic 2000 has been completed and was delivered for benchmark testing to an independent, reputable third party- eTesting Laboratories. Final testing is being conducted on this software, and Management believes that the product will be ready to market as early as the third quarter of 2002. ONSLR e2001 is a computer software product that was developed for use in various computer systems. Its purpose is to provide: significant processor speed acceleration, significant graphics display acceleration, significant drive compression and convenient keyboard enhancements. It has been successfully demonstrated, and independent testing has been commenced by eTesting Labs, Inc., a division of Ziff Davis, Inc. In addition, independent testing was conducted by Business Applications Performance Corporation of Santa Clara, CA. ("BAPco"), which was completed in July of 2001. Utilizing a benchmark software suite created by BAPco, the software formerly coded as ONSLRe2001, obtained office productivity SYSmark2000 score average of 215.6. This exceeded similarly equipped Notebook PC scores by 30-50% and established a new high for PC Desktops with heightened peripherals. The testing platform ran on a Dell Inspirion 4000 equipped with Windows 98, 128 MB and a 10 GB hard drive powered by a 700mhz processor. BAPco is a non-profit consortium, who's charter is to develop and distribute a stet of objective performance benchmarks based on popular/personal computer applications and industry standard operating systems. To learn more about BAPco, see www.bapco.com. Further testing will ensue with BAPco's Internet Creation Content module and results will then be posted on the REDOX website at www.rdox.com following notification to BAPco's membership companies including Compaq, Dell, HP, IBM, Intel, Microsoft as well as many others. In a press release dated January 31, 2001, the Company announced the selection of MDR Labs, which had not reached a definitive agreement. MDR expressed to the Company in February of 2001 that it no longer operates "MDR Labs," but MDR does perform hardware and software testing as part of its other operations. MDR had engaged in preliminary discussions with REDOX about testing the ONSLR e2001 software but has never tested any REDOX products. Currently, REDOX and MDR do not have a business relationship. Testing has been conducted, however, by BAPco and eTesting Labs. Battery Technology We have developed a high energy density battery based on an aluminum/sulfur system. The significance of the composition of the battery is in its potential capacity to serve a stronger and longer life in a much smaller size. Competition The battery market is highly competitive. There are numerous manufacturers both in the United States and overseas (especially in Japan). Many of these manufacturers have high brand recognition and established market shares with customer-perceived quality. Batteries under development today use the following chemical components, all of which have drawbacks. They are: Lead Acid--which is heavy (low energy density) and is toxic; Sodium Sulfur- which required high temperatures, is explosive, and required expensive packaging Nickel-Cadmium- that required expensive materials, is a carcinogen and has a high memory effect; Nickel metal hydride- which requires expensive material, has limited temperature range and has a high self-discharge rate; Lithium polymer- which required expensive materials, is explosive, has power density and requires long term development; Flywheel- requires long term development. 3 Aluminum Sulfur Batteries have a high capacity (demonstrated up to 220 watt-hrs/kilogram with a theoretical capacity of up to 5 times that amount in tests conducted at Clark University). Aluminum and Sulfur are comparatively lighter components than the components typically used in batteries, and are easily obtainable. Aluminum and sulfur are also considerably less expensive than components used in other batteries. The break-through patented technology that the Company obtained from Clark University makes sulfur conductive at room temperature, when previously without Clark's technology, was non-conductive and only used as an insulator. Aluminum and sulfur are not hazardous to work with. They are not toxic and can operate without becoming hot or dangerous. Also, the components produce no harmful by-products and are environmentally friendly. Aluminum and sulfur are safe even if ingested. The acids used in our batteries are pH neutral. The materials which would be used in our batteries, Aluminum and Sulfur, are common, inexpensive and readily available from many sources. We do not foresee any difficulties in acquiring raw materials or in facing any dramatic price increases due to material shortages. Information on the costs of the various battery components (chemical compounds) is publicly available. It is, in other words, easily to verify that our components are substantially less expensive than the other components used in batteries. Based on the cost of materials alone, our manufacturing costs would be lower. Additionally, we are using our inexpensive components in a highly technical system for which we have five patents issued. Our proprietary manufacturing process will allow us to lay the material on a substrate, and work on a hands-free basis in a vacuum environment, which allows for precise measurement on a continuous web process. Unlike other battery making, this process causes no contamination and no dangerous, hazardous or toxic by products. The process is also possible without the use of expensive equipment that is necessary in the manufacturing process for other batteries. In sum, the Company believes that it can enter the battery market and establish a reasonable market share because: * its raw materials (aluminum and sulfur) are readily available and less costly than those used by competitors, giving it cost advantages compared to every other battery on the market today; * its raw materials permit easier and less costly manufacturing, giving further cost advantages; * its finished products do not have explosion or other safety issues, permitting easier transportation, giving further cost advantages; * its raw materials are environmentally friendly and do not pose disposal problems; giving it an advantage with consumers concerned about the environment and waste disposal problems; * the energy densities (i.e., the amount of stored power) offered by its products are substantially higher (e.g., compared to a lithium-ion battery offering 180 - 205 watt hours per kilogram, the Company's replacement product could theoretically offer 648 watt hours per kilogram based on an independent lab's study of our design.) That energy density is substantially higher than all batteries on the market today; and * the Company's licensed electro-chemical process is a departure from current technology in that it uses different chemical components and a proprietary patented process that has not yet been employed by any other battery making process known. Electrochemically, the sulfur and the electrolyte we use, and our special patented process allows the battery to run more efficiently. Presently, we have three employees. They are: o Richard Szymanski, President/CEO; o Clifton Douglas, Vice President, Secretary; and o Nick Nasco, VP of Software Development. We do not anticipate hiring any new employees during the next twelve months. ITEM 2. PROPERTY OF THE COMPANY Offices We maintain our principal office at 340 North Sam Houston Parkway East, Suite 250, Houston, Texas 77060, where our telephone number is (281) 445-0020 and our facsimile number is (281) 445-0022. The offices are leased from a non-related party under a three year lease that commenced October 23, 2001 at an annual rental of $34,437.50 payable in monthly installments of $2,869.80. The office area is 2,755 square feet, divided into a reception area, a conference room, a file/storage/utility room and five executive offices. The Company owns the office furniture and equipment in the office. This space is adequate for current needs and our needs for the next 12 - 24 months. 4 Patents, Patent Applications and Licenses Prior to his relationship with the Company in 1993, Mr. Szymanski had been developing a battery with greater storage capacity ("density") using aluminum, magnesium and zinc. On April 8, 1993 Mr. Szymanski filed a Patent Application for an "Emergency Reserve Battery". On April 9, 1993 Mr. Szymanski assigned that Patent Application to the Company in exchange for 15,000,000 shares of the Company's Common Stock. That Patent Application is still pending in the United States Patent and Trademark Office, while the Company's primary emphasis has been on the technology under the License obtained from Clark University, Worcester, Massachusetts. On September 17, 1998 the Company entered into an exclusive License Agreement with Clark University covering U.S. Patents 5,413,881 issued May 9, 1995 and 5,571,600 issued November 5, 1996. These patents relate to batteries using aluminum and sulfur. Upon execution of the Patent License, the Company paid Clark University the sum of $30,000 as a License Fee. In addition, at the end of each year of the agreement, the Company pays a minimum royalty of $35,000. Upon the commencement of sales of products under the Patent License, the Company will pay a royalty of 5% of Gross Sales, against which the minimum royalty in that year will be applicable. The License Agreement, subject to earlier termination by Clark University in the event of the Company's default, will remain in effect until the expiration of the last patent to have been issued (Number 5,571,600 was issued November 5, 1996). In November of 1999, we issued press releases regarding an agreement that was to be finalized between ReDOX and the State of Uttar Pradesh in India for the development of a 1,500 acre technology park for ReDOX. We also filed these releases with the SEC on Form 8-K. Due to a change in administration in India, however, and various circumstantial changes which would have made it necessary for us to finance much of the project, this project has been put on hold and will not likely be revisited in the foreseeable future. On August 28, 2000, we entered into an exclusive License Agreement with Divine Logic for the exclusive worldwide marketing rights to the Divine Logic software. The Company will be required to pay 27.5% of the gross revenues from all sales of the software to Divine Logic. On May 4, 2001, we entered into an exclusive License Agreement, effective December 12, 2000m with ONSLR e2000 and a group of individuals, namely, Nick Mascia, Amit Kumar Singh, Kushal Kumar; Kashal Kumar for the exclusive worldwide marketing rights to the ONSLR e2000 software. The Company was required to pay $25,000 as an advance payment against any future royalties. The Company is not required to make any future payments until the royalties owed to ONSLR exceed $25,000. We have hired the law firm of Duane, Morris and Heckscher, LLP to file the trademark and patent applications for Divine Logic and Onslr. The trademark applications have been filed and the patent applications will be filed with the United States Patent and Trademark Office imminently. ITEM 3. LEGAL PROCEEDINGS. We are not engaged in any pending legal proceedings. We are not aware of any legal proceedings pending, threatened or contemplated, against any of our officers and directors, respectively, in their capacities as such. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. No matters were submitted to a vote of shareholders in the fourth quarter of 2001. PART II ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS. On June 29, 1993, the National Association of Securities Dealers (the "NASD") approved the Company for quotations by Brooklyn Capital, and we were listed for trading on the OTC Bulletin Board and the NQB (now "Pink Sheets, LLC") Pink Sheets. The Company's Common stock was suspended from trading in the First Quarter of 1994 due to delinquencies in certain filings. Having become current with respect to its filings, the Company sought a market maker that would reapply to the NASD to trade the Company's stock. The Company secured the services of Public Securities, Inc., Spokane, Washington, in providing market making services for the stock. Through the direct efforts of Public Securities, the NASD approved ReDOX Technology Corporation Common Stock for reinstatement and listing under the symbol "RDOX" as of May 10, 1995. Therefore, the principal United States market in which the registrant's Common Stock has been traded is the NASD Over the Counter (OTC) Bulletin Board under the symbol "RDOX". 5 The range of our prices for the past two fiscal years is as follows: Quarter High Ask Low Bid ------- -------- -------- 1st Qtr,'00 $ 0.6562 $ 0.3438 2nd Qtr,'00 $ 0.6562 $ 0.375 3rd Qtr,'00 $ 0.5625 $ 0.25 4th Qtr '00 $ 0.4688 $ 0.125 Quarter High Ask Low Bid ------- -------- -------- 1st Qtr,'01 $ 0.52 $0.17 2nd Qtr,'01 $ 0.26 $0.125 3rd Qtr,'01 $ 0.37 $0.115 4th Qtr '01 $ 0.33 $0.102 During the past three fiscal years ended 1998, 1999 and 2000, there have been no issuances of unregistered securities made by the Company. However, in 1998, Richard Szymanski converted 1,000,000 shares of his Convertible Preferred Stock to Common Stock, at a conversion rate of 5 shares of Common for each share of Preferred, providing Mr. Szymanski with 5,000,000 shares of Common Stock from that conversion. If this is recognized as an issuance, then it is considered exempt by reason of Section 4(2) of the Securities Act of 1933. In February 2001, the Company issued Mr. Szymanski, our founder, 11,937,311 shares of Common Stock in exchange for the promissory note dated August 2000 in the amount of $1,080,712. This issuance was exempt from registration by reason of Section 4(2) of the Securities Act of 1933. In April, 2001, the Company raised $120,000 through a Rule 506 private placement by selling 1,000,000 shares of Common Stock at $0.12 per share to a single individual investor. This issuance is considered exempt by reason of Section 4(2) of the Securities Act of 1933 and Regulation D of the Securities Act of 1933, and Rule 506 promulgated thereunder. On July 18, 2001, Redox issued a total of 3,302,088 shares of common stock to two officers and a consultant valued at the then trading price of $.25 per share for a total value of $825,522. This issuance is considered exempt by reason of Section 4(2) of the Securities Act of 1933. ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS The following discussion and analysis should be read in conjunction with the financial statements and summary of selected financial data for ReDOX Technology Corp. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of the management of the Company. As previously reported this corporation is in a development stage and has not yet conducted any business so as to become an income producing entity. We continue to utilize capital borrowed from our principal shareholder. Our financial condition has not changed materially from December 31, 1999 to the date of the financial statements herewith provided. We have suffered recurring losses from operations, and its current liabilities exceed our current assets. As of December 31, 2000, there was a stockholders' deficit. To the extent that we have incurred continuing expenses without any revenues having been generated, shareholder's equity would have suffered proportionately had it not been for the continuing infusion of capital from the Company's President, Richard Szymanski. We intend to continue to rely on Richard Szymanski's capital infusions to fund our operations until we begin significant sales of our licensed products. We expect that our software technologies will start generating revenues in the Fourth quarter of 2001. 6 Plan of Operation We have developed a plan of operation that covers our final testing requirements, our marketing plan and strategy, our intended methods for generating revenue, and our staffing requirements. Objective: Our objective is to initially market our software technologies to computer hardware manufactures and other original equipment manufacturers ("OEMs") before offering the technologies to the general public. It is our intention, to use a portion of the revenues generated from our software technologies to fulfill our remaining business objectives, including the completion of our research and testing required for the marketing of our battery technology. Management believes that the final development and marketing of its battery technology will be delayed at least through the second quarter of 2002. Testing: Independent testing for our software technologies has been commenced by eTesting Labs, Inc., a division of Ziff Davis, Inc. Independent testing was conducted by Business Applications Performance Corporation of Santa Clara, CA. ("BAPco"), which was completed in July of 2001. Utilizing a benchmark software suite created by BAPco, our ONSLRe2001 office productivity scores exceeded similarly equipped Notebook PC scores by 30-50%. BAPco is a non-profit consortium, who's charter is to develop and distribute a stet of objective performance benchmarks based on popular/personal computer applications and industry standard operating systems. To learn more about BAPco, see www.bapco.com. Further testing will ensue with BAPco's Internet Creation Content module and results will then be posted on the REDOX website at www.rdox.com following notification to BAPco's membership companies including Compaq, Dell, HP, IBM, Intel, Microsoft as well as many others. Products and our Target Market: Our primary software technologies consist of Divine Logic 2000 and ONSLRE e2001. 1. Divine Logic 2000, our exclusively licensed anti-piracy software program, was designed to prevent the theft of electronic information and unauthorized copying of software. We will be targeting the following industries for this product: o The computer software industry; o The music CD industry; o the DVD movie industry; o The video games industry; and o The MP3 industry. 2. ONSLR e2001, our exclusively licensed speed accelerator software product was developed to provide significant processor speed acceleration, graphics display acceleration, drive compression and convenient keyboard enhancements. We will primarily target the original equipment manufacturers ("OEMs") that make computer systems, telecommunications and data communications equipment and peripherals. Also, we will offer our software technologies to PC and computing appliance users (including individual consumers, large and small businesses, also referred to as "end users") however, direct marketing to the end user will not be our initial or primary focus. Both our software technologies will be marketed directly to OEMs, and the Company will generate its revenue on a per unit basis, i.e. one upload per unit, prior to the manufacturer's release of its product to the market place. Our President, Mr. Szymanski, has had met with more than twenty such OEMs and negotiations will progress once final test data has been released. Although our unit price has not been yet established or finalized, we intend to establish pricing for OEMs based on our marketing research and negotiation with OEMs. Upon release of final testing for both software technologies, we will begin actively pursuing the OEMs, many of which with we have already established contact and a strong level of interest. Marketing Strategy: We have retained the marketing firm of Mark Weiner Design to develop our marketing plan. Upon completion of the testing and with the release of the test data, that company will begin executing its process of product-information dissemination and its product fulfillment plan. Strategic branding, or creating name recognition through advertising in trade publications and other traditional formats, will be a primary focus of Mark Weiner Design. Marketing will progress in three phases. We anticipate our marketing costs to run approximately $100,000, which costs will not begin to in incur until the fourth quarter of 2001. 7 Phase 1 involves establishing a plan of critical reactive measures designed to provide us with the ability to react immediately to existing market conditions with the launching of our product. This short-term plan is designed to help ReDOX: 1. field product inquiries precipitated by marketing and public relations processes already in motion; 2. set up a preliminary mechanism to deliver a consistent brand message to consumer and other potential buyers; 3. provide a preliminary method to capture critical relationship data from potential consumers precipitated by any public relations and marketing efforts; 4. provide a basic infrastructure of product design and information from which to build a solid program of marketing and fulfillment. The design and functional specifications for a full e-commerce/marketing site will be developed during the end of Phase 1 for implementation in Phase 2. Phase 2 will include the tactical deployment of a targeted functional Web site. The design of the site will be based on the functional requirements identified in Phase l. Market and brand data that has been collected in Phase 1 will be analyzed and converted to action items designed to continue to build brand identity and design direction for implementation of the logo/mark and any specified marketing verbiage across the appropriate marketing channels. Phase 2 will also involve: (i) exploration of the user interface regarding user's alignment to the established brand and target market; (ii) product collateral not developed in Phase 1 (such as user guides, compatibility guides, point-of-sale collateral, brochures, etc.) will be developed during this Phase. Phase 3 involves monitoring, budgeting and planning for the projected life-cycle of the brand as well as adjusting those processes developed in prior phases. Once ReDOX has established brand identity and begins its implementation of an effective method of product information dissemination and fulfillment, Phase 3 will focus on building brand equity across multiple channels. This could include the introduction of an effective media plan for online/offline exposure, development of ad campaigns, banner campaigns, possible introduction of additional or co-brand synergies within ReDOX, development of external marketing synergies through co-branding, bundling, partnering and other promotional opportunities. All three phases can be accomplished within a 60-90 day period, and can begin upon completion of testing and release of test data for publication. Manufacturing: We will not be involved in manufacturing. The burning of CDs for our OEM customers will be done in house for a minimal cost. In the future, if we choose to market to end users, we will explore our manufacturing options at that time. During the next 12 months, we do not anticipate having any manufacturing requirements. Revenue Generation: We will generate revenue from essentially two sources: 1. OEMs will pay a royalty to the Company, based on a negotiated sub-license agreement to be drafted on a per OEM basis, for each upload of our software during their own manufacturing process. Our per-unit price will be negotiated with OEMs based on our estimated volume with each OEM. 2. Software companies will pay a royalty to the Company, based on a negotiated sub-license agreement to be drafted on a per company basis, for each unit sold. We do not expect to purchase any significant equipment over the next twelve months. We also do not expect any significant changes in the number of employees. By year-end, or the first quarter of 2002, we believe we will have a positive cash flow. This assessment is based upon the net profit we expect to earn on the sub-licensing of our software technologies and the size of the OEM marketplace. Since our manufacturing costs are insignificant in our OEM selling environment, we could reach a "break even" status fairly quickly. Battery Technologies: Our plan of operations does not include our battery technology. It is our objective to generate revenue though our software technologies over the next 12 to 24 months, and a portion of our profits will be used to complete the research and development and marketing plan necessary to launch this technology. Staffing Requirements: Over the next twelve months, we anticipate hiring a Secretary and a national sales representative. Presently, we have three employees. Over the next 24 months, we plan to build our sales force by hiring an additional four national representatives. 8 SELECTED FINANCIAL DATA (Restated) (Restated) 2001 2000 1999 1998 1997 ----- ----- ----- ----- ----- Revenues $ 0 $ 0 $ 0 $ 0 $ 0 (Loss) from continuing operations) $(1,212,314) $(427,855) $(324,288) $(168,879) $(532,820) (Loss) from continuing operations per share $(0.02) $(0.01) $(0.01) $(0.004) $(0.012) Total assets $22,534 $19,442 $20,194 $ 18,887 $ 8,981 Long term debt $ 0 $ 0 $ 0 $ 0 $ 0 The loss from continuing operations in 1997 is largely due to the issuance of 300,000 shares of common stock to a consultant for services performed valued at $459,300. Operating Data: There was no revenue from sales and ancillary income for the calendar years ended December 31, 1998, December 31, 1999, December 31, 2000, and December 31, 2001. General and Administrative expenses (operating expenses) were$287,543 in cash and 825,522 in common stock; and $259,228 in cash and 122,500 shares in common stock for the year ending December 31, 2000. Liquidity and Capital Resources: In February 2001, the Board elected to convert Mr. Szymanski's promissory note of $1,080,712 to equity of 11,937,311 shares of Common Stock, which conversion was not effectuated until September of 2001. Based upon the recommendation of the SEC, our counsel and our independent auditors, we have recalculated the conversion ratio. It now reflects 75% of the fair market value at the time of conversion, which reduced the number of number shares by 7,793,454 shares. As a result of this recalculation using a share value of $0.26 per share ($0.26 x 75%) the shares issued should have been 4,143,857. A total of 7,793,454 shares were returned to authorized in April of 2002. Mr. Szymanski has made assurances that he will continue to personally finance the Company, to the best of his ability, over the next 12 months on an as needed basis. On July 18, 2001, Redox issued a total of 3,302,088 shares of common stock to two officers and a consultant valued at the then trading price of $.25 per share for a total value of $825,522. Previously, in January 2000, the Company issued 250,000 shares of its Common Stock to two former consultants to settle a lawsuit. The Company recorded the settlement expense of $125,000 based on the fair value of the Common Stock. There were no issuances made by the Company in 1998 or 1999. In April 2001, the Company raised $120,000 through a private placement by selling 1,000,000 shares of common stock at $.12 per share to a single individual. This issuance was considered exempt by reason of Section 4(2) of the Securities Act of 1933. During the next 12 months, Management has identified specific financial demands and commitments, as well as broad financial requirements, as follows: 9 Final testing costs for software technologies: $ 20,000 Marketing Plan Development and Implementation; $ 90,000 Mark Weiner Design: Advances on Royalty Payments: $ 50,000 Working Capital: $ 75,000(1) General and Administrative: $180,000 -------- Total $415,000 (1) Amount listed under Working Capital has not yet been specifically allocated. Our commitments to our licensors, Divine Logic, ONSLR e2001 an Clark University, are all current. The sale of products using the licensed software technology (and later, battery technology) will trigger payments to our licensors. We do not anticipate that problems will arise with respect to our making such payments, as they will be paid directly out of revenues generated from sales. If required payments are not made for any unforeseen reason, however, our license agreement(s) involved may be considered in default. The Company raised $120,000 in a private placement from a single investor in April of 2001. The proceeds from that sale are being applied towards the Company's financial needs, as outlined above. Until such time that we are generating revenues sufficient to cover these expenses, Mr. Szymanski has made assurances to the Company that he will make up the difference personally. ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. The Company does not have any market risk sensitive instruments, commodity risk or any foreign currency exchange rate risk. PART III ITEM 9. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT. The following table sets forth certain information with respect to the Officers and Directors of the company. Name Age Position ---- --- -------- Richard Szymanski 60 President/Director Clifton D. Douglas 73 Secretary/Treasurer/Director James R. Schuler 65 Director The members of the Board of Directors of the Company are elected by the shareholders at each annual meeting for a one year term. Officers are elected by the Directors at each annual meeting for a one year term, or until otherwise replaced by the Board of Directors. Richard A. Szymanski is President, Chairman of the Board of Directors and CEO of our Company, serving in these capacities since our incorporation in April 1993. Mr. Szymanski is involved in research, development and improvement of high density power batteries. Mr. Szymanski previously served as Vice President and Technical Director of World Book Encyclopedia Science Service for several years where he maintained a staff of professional science writers and photographers for the purpose of writing and illustrating major scientific events, including: exclusive coverage of the seven original astronauts, organizing all photo coverage including space launchers at Cape Kennedy, and the initial heart transplants performed in Houston, Texas. Clifton D. Douglas has served as Secretary/Treasurer and Director since July 1996, overseeing and managing all of the accounting and financial affairs of the Company. From 1990 though 1995, Mr. Douglas was Vice President of Tiger Oil and Gas, Inc., Latin America Trading Company and Petrorental Internacionales, S.A., where he was responsible for operations in Mexico and Latin America. Previously, Mr. Douglas was a financial consultant in the areas of oil, gas and real estate construction. 10 In 1953, Mr. Douglas received a Bachelor of Science in Accounting from Arizona State University. James R. Schuler has served as a Director of our Company since August 4, 1998. Presently, Mr. Schuler is the President and CEO of Trans United Partners, Inc. of Pacifica, California, having been with that company since 1998. Also since 1998 through the present, Mr. Schuler is CEO to S-Cube Investments, LLC, where he has been forming a technology cooperative among new technology companies. Previously, Mr. Schuler co-founded a research and development company in 1994 called Add-Vision, Inc., which produced a new illumination technology made up of a revolutionary thin, flat, programmable display product with multiple uses (called Intelligent Illumination). He remained with Add-Vision until 1998. Prior to that, Mr. Schuler served as President and CEO to a transportation relocation company called Relocation Controls Corporation, and to petroleum refining administrative company that he founded called Transatlantic Petroleum. Mr. Schuler received a Bachelor of Science Degree in Finance and Business Administration from the University of North Carolina. Nicholas Mascia is our Vice President of Software Development and Sales, serving in that capacity since April of 2001. He also continues to hold the position of National Sales Manager of Vertima Virtual Software, Inc., a software start-up company of which he co-founded in 1995. His professional sale experience spans over 18 years, and covers the fields of PC Hardware, Application Software and 3d Design. He received his initial technical sales training at IBM Corp. in Orlando, Florida where he achieved 100% plus quota for three consecutive years. Ad Calcomp, Inc., Mr. Mascia exceeded 100% of that company's sales quota for 9 out of 10 years. He was named salesman of the year at Paradyme Corp. for generating $2.9 million in revenue. Mr. Mascia received a Bachelor of Mechanical Engineering from City College of New York, and has completed 3/4 of his M.A in Business/Education at Rollins College in Winter Park, Florida. Significant Consultant Dr. Robert Murphy is our consulting Vice President of Research and Development, having served as such since May of 1998. He has twenty years of experience in studies of chemical thermodynamics, surface chemistry, electrochemical processes in molten sales, solid electrolyte systems and high energy density battery systems. He is the founder and owner of Advanced Battery Group in Lancaster, New York where he performs research, development and engineering studies for agencies of the U.S. Government, U.S. Military and defense contractors. Dr. Murphy started that company in 1983. His prior experience in the battery research and development field is extensive, beginning in 1974 with the Rensselaer Polytechnical Institute. He holds several U.S. Patents and has had more that 25 of his studies and papers published in various science and technical journals and publications. Dr. Murphy holds a Bachelor of Science in Chemistry from the University of Maine; a Master of Science in Physical Chemistry from the University of Vermont; and a Ph.D. in Physical Chemistry from the University of Vermont. Advisory Board of Directors. We are forming Advisory Board of Directors of individuals with expertise in software, marketing and battery technology. Our first member, Lawrence C. Oakley, was asked to join our Advisory Board, and over the next 12 months, we plan to have our Board of Directors make additional appointments to the Advisory Board. During the first quarter of 2002, we hope to have an Advisory Board of at least four members. We intend to cover the expenses associated with attending meetings, and will compensate the Advisory Board with a small amount of the Company's Common Stock (the amount to be later determined) to be issued after each full year of service. Lawrence C. Oakley: Mr. Oakley ("Larry") is CEO and editor of WallStreetCorner.com, Inc., which publishes www.WallStreetCorner.com and Conservative Speculator. He has been editor of Conservative Speculator for the past 16 years. Larry has been a featured speaker at over 60 international investment conferences. Before creating Conservative Speculator, he and his wife Roseanne wrote two computer and seven investment newsletters for various publishers. Larry's early background includes several years as president of a successful electronic test equipment manufacturer whose IPO he personally underwrote; marketing director of a NYSE company; and marketing manager of the electronic component manufacturing division of a Fortune 500 company. Mr. Oakley holds a Bachelor of Mechanical Engineering from George Washington University, and a Bachelor of Science in Business Management and Accounting from College of the City of New York, where he graduated first in his class. ITEM 8. CHANGES AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. On June 12 2001, we filed a current report on Form 8-K to disclose our change in accountants. Want & Ender CPA, PC, audited our financial statements for the past seven fiscal years, including years ended December 31, 1993 through December 31, 2000 inclusive. 11 On June 12, 2001, by action of the Board of Directors, we terminated our auditor-client relationship with that firm. The report of Want & Ender CPA, PC on the financial statements did not contain an adverse opinion or disclaimer of opinion, and was not modified as to uncertainty, audit scope, or accounting principles. There were no disagreements between the Company and Want & Ender CPA, PC with respect to any matter of accounting principals or audit scope. In June of 2001, the Board of Directors appointed Malone & Bailey, PLLC, and, by action of the Board, that firm was engaged on June 12, 2001. Prior to its engagement, Malone & Bailey, PLLC was not consulted by the Company with respect to any matter. ITEM 11. EXECUTIVE COMPENSATION. Currently, our Officers are not compensated for their services. They do not receive any salary, wages or other cash remuneration. They receive no performance-based stock or options, no non-performance-based stock or options and they receive no SAR grants or deferred compensation of any kind. Annual Compensation including wages, cash remuneration of any kind, performance-based stock and options and non-performance based stock and options, SAR grants and deferred compensation of any kind for the past three years is as follows: Name Title 2001 2000 1999 ---- ----- ----- ----- ----- Richard Szymanski President -0- -0- -0- Clifton D. Douglas Secretary/Treasurer -0- -0- -0- COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT In 2001, Maria M. Douglas, wife of Clifton Douglas, sold a total pf 216,500 share of her common stock of the Company pursuant to Rule 144 of the Securities Act of 1933, as amended. In January of that year, she sold 35,000 shares; in April, she sold 30,000 shares; in September, she sold 30,000 shares; in November, she sold 75,000; and in December she sold 50,000 shares. Pursuant to Section 16(a) and 23(a) of the Securities Exchange Act of 1934, she was required, as the spouse of an affiliate, to file a Form 4 with the United States Securities and Exchange Commission as she was a deemed control person as defined by the Act. The Form 4 sets forth and discloses changes of beneficial ownership of his Common Stock of the Company. In 2001, the Clifton D.Douglas Family Trust sold a total of 299,500 shares of the Company's common stock pursuant to Rule 144 of the Securities Act of 1933, as amended. In June of that year, he sold 35,000 shares; in July, he sold 125,000 shares; in August, he sold 22,000 shares; in September, he sold 40,000 shares; and in October, he sold 77,500 shares. Pursuant to Section 16(a) and 23(a) of the Securities Exchange Act of 1934, he was required, to file a Form 4 with the United States Securities and Exchange Commission as he was a control person as defined by the Act. The Form 4 sets forth and discloses changes of beneficial ownership of his Common Stock of the Company. In 2001, the Richard Szymanski Trust#1 sold a total of 2,139,000 shares of the Company's common stock pursuant to Rule 144 of the Securities Act of 1933, as amended. In January, he sold a total of 335,000 shares; in February, he sold a total of 250,000; in March he sold a total of 452,700 shares; in April, he sold 100,700 shares; in May, he sold 90,000 shares; in June, he sold 55,000 shares; and in July, he sold 245,500 shares; in August, he sold 35,500; in September, hi sold 120,000; in October, he sold 129,999 shares; in November, he sold 93,000 share; and in December, he sold 209,400 shares. Pursuant to Section 16(a) and 23(a) of the Securities Exchange Act of 1934, he was required, to file a Form 4 with the United States Securities and Exchange Commission as he was a control person as defined by the Act. The Form 4 sets forth and discloses changes of beneficial ownership of his Common Stock of the Company. ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS Since his association with the Company in 1993, Mr. Szymanski has provided substantially all of the funding which the Company has received. From 1993 to June 30, 2000, Mr. Szymanski has advanced a total of $1,080,712 to the Company. In addition, Mr. Szymanski has served as Chairman of the Board, Vice President or President, and as the primary employee during that same period without compensation. In 1996, in an effort to recognize Mr. Szymanski's contributions, the Board of Directors authorized the issuance of 6,000,000 shares of a series of Convertible Preferred Stock which was designated for that purpose. This issuance was based upon a then recent Amendment to the Certificate of Incorporation which had authorized 10,000,000 shares of undesignated Preferred Stock having a par value of $.001 per share. In reliance upon that issuance, the advances made by Mr. Szymanski prior to that date were booked as "Additional Paid In Capital". Furthermore, Mr. Szymanski continued to make all necessary cash advances and in reliance upon the issuance of the Convertible Preferred Stock those were also booked as "Additional Paid In Capital". In 12 essence, Mr. Szymanski's advances were treated as capital contributions. During the second quarter of 2000, questions were raised about the validity of the 1996 Amendment to the Certificate of Incorporation since the proxies used for the required vote of the stockholders had been solicited without the use of a definitive Proxy Statement filed in accordance with the Proxy Rules of the Securities and Exchange Commission. To resolve the problem, the Board and Mr. Szymanski rescinded the issuance with respect to the 5,000,000 shares of Convertible Preferred Stock still held by his trust, issued him a Promissory Note for the $1,080,712 in advances, and agreed to develop an alternative plan to recognize his advances and convert the Promissory Note back to equity. The Board has approved the issuance of the Promissory Note and subsequent conversion of that Note to equity. Even though only 5,000,000 of the 6,000,000 shares of Convertible Preferred Stock were canceled, the Board elected to issue the Promissory Note for the full amount advanced. The other 1,000,000 shares of Convertible Preferred had already been converted. The Board has decided that With respect to those 1,000,000 shares, they were issued to Mr. Szymanski as "founder's shares," independent of the shares issued in exchange for his rescission of the 5,000,000 shares of preferred. The Promissory Note bore no interest through December 31, 2000 (the Maturity Date), but provided that if not paid in full or before that the Maturity Date, interest would be retroactively applicable for the period from the date of the Note, August 14, 2000, through the Maturity Date at a rate of 10% per annum, simple interest, and after the passage of the Maturity Date, the Company (or Borrower) would be considered in default. Unpaid principal and unpaid interest thereon would be retroactively calculated bearing an interest rate of 18% per annum until paid. The Board approved Mr. Szymanski's conversion of the Note to equity, and issued him 11,937,311 shares of our Common Stock in February of 2001. This was later recalculated. We filed a Proxy Statement with the SEC in September of 2000 to disclose what we believed to be a possible violation of Section 14, and to disclose other matters. Specifically, a Certificate of Amendment was approved by the Board to increase the Company's capital structure, and an amendment to our Certificate of Incorporation was subsequently filed with the Delaware Secretary of State. Shares of stock were issued, and we became concerned after a consultation with a securities lawyer that there may have been a problem with the shares that were issued since the Certificate of Amendment was not presented to our shareholders in accordance with the Section 14 Proxy Regulations. We filed a preliminary proxy statement in an effort to remedy our perceived deficiency or violation. After responding to comments from the Commission on that Statement, and conducting research with regard to the applications of Section 15(d) of the Securities Exchange Act of 1934 to companies such as ReDOX that are reporting solely because their Registration Statements were declared effective under the Securities Act of 1933, we concluded, that there was no violation since the Company was not subject to Section 14 Proxy Regulation. We have since communicated the amendment and other matters with our shareholders in accordance with Delaware Corporation Law. Our Board of Directors approved an issuance to Mr. Szymanski of 11,937,311 shares of Common Stock in conversion of the Promissory Note. The number of shares was arrived at by taking the advances made to 1996 and dividing that total by one-half of the then market price per share (which amounted to 0.045) and by taking the further advances to June 30, 2000 and dividing that total by $.20 per share, which was more or less the average bid and ask price during the period of those advances. The issuances amounts were initially calculated as follows: Advances Conversion Shares Rate $379,379 to 6/30/96 $0.045 8,430,644 $701,333 to 6/30/00 $0.20 3,506,667 The calculation employed by the Board to arrive at that number of shares was considered to be a fair method of calculation. The shares issued to Mr. Szymanski were restricted, and he and the Board felt that as such, the stock should have a reduced value. Prior to the issuance of the Promissory Note, and subsequent conversion thereof, Mr. Szymanski had no formal loan documents with the Company, and therefore, there were no repayment terms. In February 2001, the Board elected to convert Mr. Szymanski's promissory note of $1,080,712 to equity of 11,937,311 shares of Common Stock, which conversion was not effectuated until September of 2001. Based upon the recommendation of the SEC, our counsel and our independent auditors, we have recalculated the conversion ratio to 13 reflect 75% of the fair market value at the time of conversion, which reduced the number of number shares by 7,793,454 shares. As a result of this recalculation using a share value of $0.26 per share ($0.26 x 75%) the shares issued should have been 4,143,857. A total of 7,793,454 shares were returned to authorized in April of 2002. On July 18, 2001, Redox issued a total of 3,302,088 shares of common stock to two officers and a consultant valued at the then trading price of $.25 per share for a total value of $825,522. These issuances were considered exempt by reason of Section 4(2) of the Securities Act of 1933. ITEM 13. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT. The following table sets forth, as of June 20, 2001, information regarding the beneficial ownership of shares of our Common Stock by each person known by us to own five percent or more of the outstanding shares of Common Stock, by each of our Officers, by each of our Directors, and by our Officers and Directors as a group. On June 20, 2001 there were 50,953,439 shares issued and outstanding of record. Name and Address of Number of Percent Beneficial Owner Common Shares As of 4/20/02(1) - ------------------- --------------- --------------- Richard Allen Szymanski 50,000 .08% 15 White Oak Manor Conroe, Texas 77304 Richard Alan Szymanski Trust #1 17,069,856(2) 29% 15 White Oak Manor Conroe, Texas 77304 Clifton D. Douglas 352,160(4) 0.6% 14674 F. Perthshire Houston, Texas 77079 Clifton D. Douglas Family Trust 1,507,833 2.54% 14674 F. Perthshire Houston, Texas 77079 James R. Schuler -0- -0- 1141 Harbor Bay Parkway Alameda, CA 94502 All officers and directors as a group(3) 18,979,849 32.22% - ---------------------- (1) Based on 59,395,945 shares of Common Stock issued and outstanding as of 4/20/02. (2) These shares were placed in a trust, The Richard Alan Szymanski Trust #1, for the benefit of Patricia Szymanski, Wendy Szymanski, Jonathan Szymanski and Holly Szymanski. The total presented reflects the conversion of the outstanding Note Payable of $1,080,712 into 4,156,585 shares (which was initially calculated to convert into 11,937,311 but was recalculated). The recalculation was approved by the board upon recommendation of the SEC, counsel and the Company's independent auditor. (4) These shares have been transferred by Mr. Douglas to his wife. Mr. Douglas may have a beneficial interest in these shares. 14 Number of Name and Address of Preferred Shares Percent Beneficial Owner (2001 Series) As of 6/20/01(1) - --------------- ------------------- --------------- Richard Alan Szymanski -0- -0- Trust #1 15 White Oak Manor Conroe, Texas 77304 Clifton D. Douglas -0- -0- 14674 F. Perthshire Houston, Texas 77079 James R. Schuler -0- -0- 1141 Harbor Bay Parkway Alameda, CA 94502 All officers and directors as a group(3) -0- -0- - ---------------------- (1) Based on -0- shares of the 2001 Series of Convertible Preferred Stock after the rescission of Richard Szymanski of 5,000,000 shares. PART IV ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K 3.1*^ Certificate of Incorporation, filed April 25, 1988 3.2* By-laws 3.3 Certificate of Amendment, filed June 7, 1993 3.4** By-laws of June 1993 3.5*^ Certificate of Amendment, filed July 5, 1994 3.6*^ Certificate of Amendment, filed September 12, 1996 3.7*^ Certificate of Amendment, filed February 19, 2001 4.1** Designation of Convertible Preferred Stock 10.1** License Agreement with Clark University 10.2** Indemnification Agreement with Richard A. Szymanski 10.3** Indemnification Agreement with Clifton D. Douglas 10.4** Indemnification with James R. Schuler 10.5*** License Agreement with Onsler e2000 10.5*** License Agreement with Divine Logic 15 10.6*^ Promissory Note with Richard Szymanski 10.7*^ Letter Agreement with eTesting Labs * Previously filed in our 1996 10-K. ** Previously filed in our 1999 10-K, amendment number 2. *** Previously filed in our 2000 10-K. *^ Previously filed in our 2000 10-K amendment SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Security Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. REDOX TECHNOLOGY CORPORATION By: /s/ Richard A. Szymanski ---------------------------------- Richard A. Szymanski, President Date: April 30, 2002 By: /s/ Clifton D. Douglas ---------------------------------- Clifton D. Douglas, CFO Date: April 30, 2002 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following person on behalf of the registrant in the capacities and on the dates indicated. /s/ Clifton D. Douglas ----------------------------- Clifton D. Douglas, Director Date: April 30, 2002 16 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) BALANCE SHEETS As of December 31, 2001 and 2000 (Restated) 2001 2000 ----------- ----------- ASSETS Cash $ 305 $ 633 Property and equipment, net of $44,664 and $39,384 accumulated depreciation 19,359 17,650 Security deposits 2,870 1,159 ----------- ----------- Total Assets $ 22,534 $ 19,442 =========== =========== LIABILITIES Accounts payable $ 69,745 $ 30,011 Note payable to founder 1,121,239 ----------- ----------- Total Liabilities 69,745 1,151,250 ----------- ----------- STOCKHOLDERS' DEFICIT Convertible Preferred stock, $.001 par, 10,000,000 shares authorized, 0 and 0 shares outstanding, respectively Common stock, $.00005 par, 100,000,000 shares authorized, 59,395,945 and 50,950,000 shares outstanding respectively 2,969 2,547 Additional paid in capital 4,052,845 1,756,356 Deficit accumulated during the development stage (4,103,025) (2,890,711) ----------- ----------- Total Stockholders' Deficit ( 47,211) (1,131,808) ----------- ----------- TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 22,534 $ 19,442 =========== =========== See accompanying summary of accounting policies and notes to financial statements. F-1 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) STATEMENTS OF EXPENSES For the Years Ended December 31, 2001, 2000, and 1999, and the Period from April 9, 1993 (Inception) Through December 31, 2001 Inception Through (Restated) (Restated) Dec. 31, 2001 2000 1999 2001 ----------- ----------- ----------- ----------- General & administrative - paid in cash $ 287,543 $ 259,228 $ 319,737 $ 1,488,693 - paid in stock 825,522 122,500 2,435,172 Research & development 66,882 66,882 Interest 25,228 40,527 65,755 Depreciation 7,139 5,600 4,551 46,523 ----------- ----------- ----------- ----------- Net loss $(1,212,314) $ (427,855) $ (324,288) $(4,103,025) =========== =========== =========== =========== Net loss per common share $(.02) $(.01) $(.01) Weighted average common shares outstanding 56,755,999 50,950,000 50,700,000 See accompanying summary of accounting policies and notes to financial statements. F-2 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) For the Period from April 9, 1993 (Inception) Through December 31, 2001 (Restated) Preferred Stock Common Stock Shares $ Shares $ ------------ ------- ------------ ------- Shares issued - - to founder for patent 15,000,000 $1,500 - - for acquisition of DCUSA 3,000,000 300 Reverse 1 for 10 stock split (16,200,000) Options issued to 5 directors for services rendered Options exercised by 5 directors 300,000 300 Forward 20 for 1 stock split 39,900,000 Additional shares issued due to error in original split 2,100,000 105 Cash contributed by founder Options issued to an officer for services Options exercised by an officer 1,000,000 50 Shares issued for services 6,000,000 $6,000 600,000 30 Conversion of preferred stock to common stock (1,000,000) (1,000) 5,000,000 250 Deficit accumulated during the development stage ------------ ------- ------------ ------- Balances at December 31, 1998 5,000,000 5,000 50,700,000 2,535 Cash contributed by founder Net loss ------------ ------- ------------ ------- Balances at December 31, 1999 5,000,000 5,000 50,700,000 2,535 Shares issued for settlement of a lawsuit 250,000 12 Cancellation of preferred shares (5,000,000) (5,000) Reclassify additional paid in capital to note payable to founder Cash contributed by founder Net loss ------------ ------- ------------ ------- Balances at December 31, 2000 0 0 50,950,000 2,547 Shares issued for - - cash 1,000,000 50 - - services 3,302,088 165 - - note payable to founder 4,143,857 207 Cash contributed by founder Net loss ------------ ------- ------------ ------- Balances at December 31, 2001 0 $ 0 59,395,945 $2,969 ============ ======= ============ ======= See accompanying summary of accounting policies and notes to financial statements. F-3 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) For the Period from April 9, 1993 (Inception) Through December 31, 2001 (Restated) Deficit Accumulated Additional During The Paid in Development Capital Stage Totals ----------- ----------- ----------- Shares issued - - to founder for patent $ 1,500 - - for acquisition of DCUSA $( 300) 0 Reverse 1 for 10 stock split Options issued to 5 directors for services rendered 14,700 14,700 Options exercised by 5 directors 300 Forward 20 for 1 stock split Additional shares issued due to error in original split ( 105) 0 Cash contributed by founder 663,134 663,134 Options issued to an officer for services 129,950 129,950 Options exercised by an officer 50 Shares issued for services 1,334,970 1,341,000 Conversion of preferred stock to common stock 750 Deficit accumulated during the development stage $(2,138,568) (2,138,568) ----------- ----------- ----------- Balances at December 31, 1998 2,143,099 (2,138,568) 12,066 Cash contributed by founder 316,136 316,136 Net loss ( 324,288) ( 324,288) ----------- ----------- ----------- Balances at December 31, 1999 2,459,235 (2,462,856) 3,914 Shares issued for settlement of a lawsuit 122,488 122,500 Cancellation of preferred shares 5,000 Reclassify additional paid in capital to note payable to founder (1,080,712) (1,080,712) Cash contributed by founder 250,345 250,345 Net loss ( 427,855) ( 427,855) ----------- ----------- ----------- Balances at December 31, 2000 1,756,356 (2,890,711) (1,131,808) Shares issued for - - cash 119,950 120,000 - - services 825,357 825,522 - - note payable to founder 1,146,260 1,146,467 Cash contributed by founder 204,922 204,922 Net loss (1,212,314) (1,212,314) ----------- ----------- ----------- Balances at December 31, 2001 $ 4,052,845 $(4,103,025) $( 47,211) =========== =========== =========== See accompanying summary of accounting policies and notes to financial statements. F-4 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) STATEMENTS OF CASH FLOWS For the Years Ended December 31, 2001, 2000, and 1999, and the Period from April 9, 1993 (Inception) Through December 31, 2001 Inception Through (Restated) (Restated) Dec. 31, 2001 2000 1999 2001 ----------- ----------- ----------- ----------- CASH FLOWS FROM OPERATING ACTIVITIES Net loss $(1,212,314) $ (427,855) $ (324,288) $(4,103,025) Adjustments to reconcile net loss to cash used by operating activities: Stock issued for lawsuit 122,500 122,500 Stock issued for patent 1,500 Stock issued for services 825,522 2,311,172 Depreciation 7,139 5,600 4,551 46,523 Accrued interest 25,228 40,527 65,755 Increase in deposits ( 1,711) ( 2,870) Increase in accounts payable 39,734 13,731 9,459 69,745 ----------- ----------- ----------- ----------- NET CASH USED IN OPERATING ACTIVITIES ( 316,402) (245,497) (310,278) (1,488,700) ----------- ----------- ----------- ----------- CASH FLOWS FROM INVESTING ACTIVITIES Purchase of fixed assets ( 8,848) ( 7,448) ( 2,811) ( 65,882) ----------- ----------- ----------- ----------- CASH FLOWS FROM FINANCING ACTIVITIES Sales of common stock 120,000 120,350 Contributions to capital by founder 204,922 250,345 316,136 1,434,537 ----------- ----------- ----------- ----------- NET CASH PROVIDED BY FINANCING ACTIVITIES 324,922 250,345 316,136 1,554,887 ----------- ----------- ----------- ----------- NET INCREASE (DECREASE) IN CASH ( 328) ( 2,600) 3,047 305 CASH AT BEGINNING OF PERIOD 633 3,233 186 0 ----------- ----------- ----------- ----------- CASH AT END OF PERIOD $ 305 $ 633 $ 3,233 $ 305 =========== =========== =========== =========== SUPPLEMENTAL DISCLOSURES: Interest paid $ 0 $ 0 $ 0 $ 0 Income taxes paid 0 0 0 0 NONCASH ACTIVITIES: Paid in capital converted into note to founder 1,080,712 1,080,712 Note to founder exchanged for common stock (1,146,467) (1,146,467) See accompanying summary of accounting policies and notes to financial statements. F-5 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) NOTES TO FINANCIAL STATEMENTS NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Business. On April 15, 1988 Family Health Systems, Inc. formed DCUSA Corporation as a wholly owned subsidiary, receiving 3,000,000 shares of DCUSA. DCUSA was incorporated in Delaware on April 25, 1988. On April 9, 1993, DCUSA was acquired through a reverse acquisition by Richard Szymanski, a sole proprietor, and on June 1, 1993 the name was changed to Redox Technology Corporation ("Redox"). In the acquisition, Mr. Szymanski received 83%, or 15,000,000 shares of DCUSA in exchange for a pending patent application for an Emergency Reserve Battery. Restatements of 1999 and 2000 were made. See Note 9 for details. Estimates and assumptions that affect amounts reported are used by management to prepare these financial statements and accompanying footnotes in conformity with accounting principles generally accepted in the United States. Actual results could differ from those estimates. Cash and Cash Equivalents. For purposes of the statements of cash flows, Redox considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Depreciation is currently being provided on the property and equipment used by Redox using the straight line method over an estimated useful life of five years for all computers, equipment, and furniture. Assets purchased in 1994 from the founder were recorded at the founder's original cost less an appropriate reserve for accumulated depreciation. The assets had no remaining book value at December 31, 2000. Income taxes. Redox recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. Redox provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not. Loss per common share is calculated by dividing the net loss by the weighted average shares outstanding. There are no dilutive securities. Stock options and warrants. Redox accounts for stock options and warrants issued to employees under the intrinsic value method. Under this method, Redox recognizes no compensation expense for stock options or warrants granted when the number of underlying shares is known and exercise price of the option or warrant is greater than or equal to the fair market value of the stock on the date of grant. Recently issued accounting pronouncements. Redox does not expect the adoption of recently issued accounting pronouncements to have a significant impact on Redox results of operations, financial position or cash flow. F-6 NOTE 2 NOTE PAYABLE TO FOUNDER Mr. Szymanski has advanced Redox $1,434,537 from inception through December 31, 2001. From inception through August 2000, Redox recorded these advances as contributions to capital. As of August 2000, the advances totaled $1,229,615. In August 2000, Redox issued a promissory note in the amount of $1,080,712 to Mr. Szymanski, bearing interest at 10% and due December 31, 2000. After December 31, 2000, the principal and accrued interest bore interest at 18% until paid. The balance of $148,903 was still carried as a contribution to capital from Mr. Szymanski. On February 18, 2001, Redox issued the founder 4,143,857 shares of common stock in exchange for the principal of $1,080,712 and accrued interest of $65,755. The number of shares issued was determined by dividing the principal and interest of $1,146,467 by the closing price of the stock on February 18, 2001 less a nominal discount because the shares were not freely salable. The share price used was $.28 per share. NOTE 3 INCOME TAXES Deferred tax assets $ 510,509 Less: valuation allowance (510,509) --------- Net deferred taxes $ 0 ========= Redox has net operating losses of $324,288, $264,828, and $361,564 at December 31, 1999, 2000 and 2001 respectively which each can be carried forward 20 years. NOTE 4 CAPITAL COMMON STOCK Redox is authorized to issue up to 100,000,000 shares of its $.00005 par value common stock. The holders of common stock are entitled to receive dividends, if any, as may be declared by the Board of Directors from time to time out of legally available funds, only after all dividends declared and due to preferred shareholders have been paid. The holders of common stock are entitled to one vote for each share on all matters submitted to a vote of stockholders. Upon liquidation or dissolution of Redox, the holders of common stock are entitled to share ratably in all assets of Redox that are legally available for distribution, after payment of all debts and other liabilities and subject to the priority rights of any holders of preferred stock then outstanding. PREFERRED STOCK Redox is authorized to issue up to 10,000,000 shares of its $.001 par value preferred stock. The preferred stock may be issued in one or more series, the terms of which may be determined by the Board of Directors, and may include voting rights, preferences as to dividends and liquidation, limitations and relative rights provisions. F-7 NOTE 5 STOCK ISSUANCES At inception, Redox issued 15,000,000 shares of common stock to the founder in exchange for a pending patent. The shares were valued at par because all costs incurred by the founder were previously expensed as research and development. The total value of the issuance was $1,500. In connection with the reverse acquisition, Redox issued 3,000,000 shares to the former shareholders of DCUSA at par for a total value of $300. On June 25, 1993, the board of directors approved a reverse 10 to 1 split of the common stock, decreasing the then 18,000,000 shares outstanding to 1,800,000 shares outstanding. On July 20, 1993, Redox issued 300,000 options to purchase Redox's common stock to 5 directors for services performed at an exercise price of par or $.00005 per share. The options were immediately exercised upon grant and recorded at their fair value of $.05 per share or $15,000. On May 26, 1994, the board of directors approved a forward 20 for 1 split of the common stock, increasing the then 2,100,000 shares outstanding to 42,000,000 shares outstanding. In error, an additional 2,100,000 shares were issued in connection with the split effectively making it a 21 for 1 split with 44,100,000 shares outstanding following the split. The board has decided to leave the split as issued at 21 for 1. On July 6, 1995 Redox issued 300,000 shares to First London for consulting services. The shares were valued at fair value of $.05 per share or $15,000. On July 1, 1996 Redox issued 1,000,000 options to purchase Redox's common stock to an officer for an exercise price of par or $.00005 per share. The options were immediately exercised upon grant and recorded at the then trading price of $.13 per share or $130,000. On August 8, 1996, Redox issued 6,000,000 shares of Redox's preferred stock to the founder for past services valued at the then trading price of $.09 per share for a total of $540,000. The preferred stock was convertible to common stock on a 5 for 1 ratio. On September 26, 1997, Redox issued 300,000 shares to a consultant for services performed. The shares were valued at the then trading price of $2.62 per share for a total value of $786,000. In September 1998, the founder converted 1,000,000 shares of preferred stock to 5,000,000 shares of common stock. In January 2000, Redox issued 250,000 shares of its common stock to two former consultants to settle a lawsuit. Redox recorded a settlement expense of $122,500 based on the then trading price of $.49 per share. On July 14, 2000, the founder returned the remaining 5,000,000 shares of preferred stock to Redox. On April 24, 2001, Redox raised $120,000 through a private placement by selling 1,000,000 shares of common stock at $.12 per share to a single individual. F-8 On July 18, 2001, Redox issued a total of 3,302,088 shares of common stock to two officers and a consultant valued at the then trading price of $.25 per share for a total value of $825,522. NOTE 6 OFFICE LEASE Redox's office lease was $1,643 per month and expired March 31, 2001. The lease was extended in April 2001 on a month to month basis for $1,985 per month. In October 2001 the lease was renewed until October 31, 2004. The office space was increased, resulting in monthly rent from November 1, 2001 through October 31, 2002 of $2,640 per month. Beginning November 1, 2002 through October 31, 2004, the rent will increase to $2,870 per month. At the time of renewal, an additional security deposit was required bringing the total security deposit to $2,870. Redox incurred rent expense of $24,104, $23,820 and $23,820 in 2001, 2000 and 1999 respectively. NOTE 7 OFFICER COMPENSATION There are two officers, each of whom work part time. Neither has an oral or written contract. The only compensation received has been in the form of shares of Redox preferred and common stock and options to purchase Redox stock. NOTE 8 CONTRACTS AND AGREEMENTS On September 17, 1998, Redox entered into a license agreement with Clark University ("Clark") for the use of two patents owned by Clark. The agreement required an up front payment of $30,000 to Clark and a minimum annual payment of $35,000 to be paid to Clark as well as 5% of the gross sales of the licensed products and 20% of any payments Redox received while sub-licensing the two patents. All amounts due have been expensed. As of December 31, 2001, there have been no sales or sub-licensing under this agreement. On August 28, 2000, Redox entered into a license agreement with Divine Software Developing Center for use of the Divine Logic Software. Redox will be required to pay a royalty of 27.5% of the gross revenues from all sales of the software. As of December 31, 2001, there have been no sales under this agreement. On May 4, 2001 Redox entered into a license agreement effective December 12, 2000, with ONSLR for exclusive use of the ONSLR software. Redox paid $25,000 as an advance payment against any future royalties. Redox is not required to make any future payments until the royalties owed to ONSLR exceed the $25,000. As of December 31, 2001, there have been no sales under this agreement. NOTE 9 RESTATEMENT OF PREVIOUSLY REPORTED FINANCIAL STATEMENTS In prior years, stock and options issued to employees and outsiders were not recorded at their fair market value. From inception through December 31, 1997, 6,000,000 shares of preferred stock, 600,000 shares of common stock, and 1,300,000 options to purchase common stock at par were issued for services. After considering the fair market value of each issuance, based on F-9 trading price for the day of each issuance, an additional $1,540,340 has been expensed and credited to paid in capital in connection with these services. In prior years, $50,000 of goodwill was carried on the balance sheet originally recorded as paid in capital. After review, this was an error. The goodwill should not have been recorded and has been corrected as of December 31, 1997 and a reduction to paid in capital for $50,000 has been made. In prior years, $21,750 of intangibles were carried on the balance sheet. After review, the intangibles were fully impaired as of December 31, 1997 and the $21,750 has been expensed as of December 31, 1997. For the year ended December 31, 1998, depreciation expense and accumulated depreciation were re-examined and both were increased by $375. Unrecorded liabilities of $1,133 have now been recorded and a $30,000 intangible was determined to be impaired and has been expensed. Common stock was decreased by $750 and additional paid in capital was increased by $750 to adjust to the actual outstanding amounts. For the year ended December 31, 1999, depreciation expense and accumulated depreciation were re-examined and decreased by $2,649 and increased by $2,751, respectively. In connection with the adjustments to depreciation expense and accumulated depreciation, additional paid in capital was decreased by $5,400 due to certain fixed assets being incorrectly credited to additional paid in capital. For the year ended December 31, 2000, fixed assets were re-examined and a decrease to both accumulated depreciation and depreciation expense of $700 was made. An increase to fixed assets of $2,598, and an increase to additional paid in capital of $2,598 was needed for fixed assets contributed by the majority stockholder. Unrecorded accounts payable and accrued interest of $4,423 and $40,527 respectively, have since been recorded. An increase of $12 and $122,488 to common stock and additional paid in capital respectively, have been recorded for the settlement of a lawsuit. A decrease to additional paid in capital and an increase to common stock of $3,323 and $805 respectively, was needed to adjust these accounts to their actual amounts. A summary of these changes is as follows: Previously Increase For the year ended December 31, 1999: Stated (Decrease) Restated ----------- ----------- ----------- Statement of Expenses: General & administrative - paid in cash $ 319,737 $ 319,737 Depreciation 7,200 $( 2,649) 4,551 ----------- ----------- ----------- Net loss $( 326,937) $ 2,649 $( 324,488) =========== =========== =========== Net loss per common share nothing presented $(.01) $(.01) Weighted average common shares outstanding nothing presented 50,700,000 50,700,000 F-10 Previously Increase For the year ended December 31, 2000: Stated (Decrease) Restated ----------- ----------- ----------- Balance Sheet: Cash $ 633 $ 633 Property & equipment, net 17,478 $ 172 17,650 License agreement 50,000 ( 50,000) 0 Patent 1,500 ( 1,500) 0 Security deposits 1,159 1,159 Goodwill 50,000 ( 50,000) 0 Organization costs, net 250 ( 250) 0 ----------- ----------- ----------- Total assets $ 121,020 $( 101,578) $ 19,442 =========== =========== =========== Accounts payable $ 24,455 $ 5,556 $ 30,011 Note payable to founder 1,080,712 40,527 1,121,239 Common stock 2,480 67 2,547 Additional paid in capital 148,903 1,607,453 1,756,356 Deficit accumulated during the development stage (1,135,530) (1,755,181) (2,890,711) ----------- ----------- ----------- Total liabilities and equity $ 121,020 $( 101,578) $ 19,442 =========== =========== =========== Statement of Expenses: General & administrative - paid in cash $ 257,323 $ 1,905 $ 259,228 - paid in stock 122,500 122,500 Interest expense 40,527 40,527 Depreciation 6,300 ( 700) 5,600 ----------- ----------- ----------- Net loss $( 263,623) $( 164,232) $( 427,855) =========== =========== =========== Net loss per common share nothing presented $(.01) $(.01) Weighted average common shares outstanding nothing presented 50,950,000 50,950,000 NOTE 10 FUNDING COMMITMENT Redox has had no revenues and has incurred significant losses since inception. However, current overhead cost is minimal. The founder and majority shareholder has orally committed to fund ongoing operations. NOTE 11 QUARTERLY FINANCIAL DATA (UNAUDITED) Summary data relating to the results of operations for each quarter of the years ended December 31, 2001 and 2000 is as follows: F-11 ------------Three Months Ended----------- Mar. 31 June 30 Sept. 30 Dec. 31 -------- -------- -------- -------- 2001: General & administrative expenses $ 50,583 $112,683 $860,531 $ 89,268 Depreciation 1,627 1,924 1,729 1,859 Net loss (88,438) (141,350) (880,399) (102,127) Net loss per common share ( .00) ( .00) ( .01) ( .00) ------------Three Months Ended----------- Previously Previously Stated Restated Stated Restated Mar. 31 Mar. 31 June 30 June 30 -------- -------- -------- -------- 2000: General & administrative expenses $ 36,722 $159,222 $ 67,678 $ 72,123 Interest Depreciation 1,800 1,230 1,500 1,229 Net loss (38,522) (160,452) (69,178) (73,352) Net loss per common share none ( .00) none ( .00) ------------Three Months Ended----------- Previously Previously Stated Restated Stated Restated Sept. 30 Sept. 30 Dec. 31 Dec. 31 -------- -------- -------- -------- 2000: General & administrative expenses $108,481 $104,116 $ 44,442 $ 46,267 Interest 13,509 27,018 Depreciation 1,500 1,539 1,500 1,602 Net loss (109,981) (119,164) (45,942) (74,887) Net loss per common share none ( .00) none ( .00) For details on restated numbers, see note 9. F-12 INDEPENDENT AUDITORS REPORT To the Board of Directors Redox Technology Corporation (A Development Stage Company) Houston, Texas We have audited the accompanying balance sheets of Redox Technology Corporation (a development stage company), as of December 31, 2001 and 2000, and the related statements of expenses, stockholders' deficit, and cash flows for each of the three years ended December 31, 2001 and the period from April 9, 1993 (Inception) through December 31, 2001. These financial statements are the responsibility of Redox's management. Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Redox Technology Corporation (a development stage company), as of December 31, 2001 and 2000, and the results of its operations and its cash flows for each of the three years ended December 31, 2001 and the period from April 9, 1993 (Inception) through December 31, 2001 in conformity with accounting principles generally accepted in the United States. As discussed in Note 9 to the financial statements, certain errors resulting in an understatement of previously reported par value of common stock, additional paid in capital, and deficit accumulated during the development stage as of December 31, 2000, were discovered by management of Redox during the current year. Accordingly, adjustments have been made as of December 31, 2000, to correct the errors. MALONE & BAILEY, PLLC Houston, Texas www.malone-bailey.com February 27, 2002